Figure 2
Figure 2. Enhancer activities associated with the Ikzf1 regulatory sites. (A) Diagrams of the reporter constructs used in this study are shown on the left. The number of GFP-expressing founders is displayed over the total number of founders obtained for each reporter. The statistical significance of the difference (increase) in GFP-expressing founder lines compared with the parental B-p-GFP lines was provided by χ2 analysis and is shown as a P value. (B) The percentage of GFP+ PBLs assessed by flow cytometry is depicted for each founder line as circles. The average percentage of GFP+ PBLs for each transgenic reporter was calculated for either all GFP-expressing founders (black bar) or all founders (gray bar). (C) The MFI of GFP+ PBLs was estimated for each founder line (gray diamonds) of every transgenic reporter as described in panel B.

Enhancer activities associated with the Ikzf1 regulatory sites. (A) Diagrams of the reporter constructs used in this study are shown on the left. The number of GFP-expressing founders is displayed over the total number of founders obtained for each reporter. The statistical significance of the difference (increase) in GFP-expressing founder lines compared with the parental B-p-GFP lines was provided by χ2 analysis and is shown as a P value. (B) The percentage of GFP+ PBLs assessed by flow cytometry is depicted for each founder line as circles. The average percentage of GFP+ PBLs for each transgenic reporter was calculated for either all GFP-expressing founders (black bar) or all founders (gray bar). (C) The MFI of GFP+ PBLs was estimated for each founder line (gray diamonds) of every transgenic reporter as described in panel B.

Close Modal

or Create an Account

Close Modal
Close Modal